ESPL1 and hepatocellular carcinoma: In NA-treated patients, a prospective study using liver tissue from people with CHB reported that human ESPL1-HBV S fusion gene was detected in 8 of 12 (66.7%) people with HCC, compared to 0 of 11 (0%) CHB patients without HCC (Hu et al., 2020).